360 related articles for article (PubMed ID: 18300861)
1. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.
Attinà TM; Malatino LS; Maxwell SR; Padfield PL; Webb DJ
J Hypertens; 2008 Mar; 26(3):501-7. PubMed ID: 18300861
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase type 5 inhibition improves arterial stiffness after exercise but not exercise capacity in hypertensive men.
Attinà TM; Drummond ID; Malatino LS; Maxwell SR; Webb DJ
Am J Hypertens; 2013 Mar; 26(3):342-50. PubMed ID: 23382484
[TBL] [Abstract][Full Text] [Related]
3. The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men.
Dishy V; Sofowora G; Harris PA; Kandcer M; Zhan F; Wood AJ; Stein CM
Clin Pharmacol Ther; 2001 Sep; 70(3):270-9. PubMed ID: 11557915
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of a single dose of phosphodiesterase type 5 inhibitor (sildenafil) on systemic arterial blood pressure during exercise and 24-hour ambulatory blood pressure monitoring in heart transplant recipients.
Guimaraes GV; d'Avila VM; Pires P; Bacal F; Stolf N; Bocchi E
Transplant Proc; 2007 Dec; 39(10):3142-9. PubMed ID: 18089340
[TBL] [Abstract][Full Text] [Related]
5. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model.
Turgut NH; Temiz TK; Bagcivan I; Turgut B; Gulturk S; Karadas B
Eur J Pharmacol; 2008 Jul; 589(1-3):180-7. PubMed ID: 18538317
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic sildenafil treatment on penile endothelial function: a randomized, double-blind, placebo controlled study.
Vardi Y; Appel B; Ofer Y; Greunwald I; Dayan L; Jacob G
J Urol; 2009 Dec; 182(6):2850-5. PubMed ID: 19837434
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
[TBL] [Abstract][Full Text] [Related]
8. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.
Melenovsky V; Al-Hiti H; Kazdova L; Jabor A; Syrovatka P; Malek I; Kettner J; Kautzner J
J Am Coll Cardiol; 2009 Aug; 54(7):595-600. PubMed ID: 19660688
[TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
10. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients.
Guazzi M; Casali M; Berti F; Rossoni G; Colonna VD; Guazzi MD
Clin Pharmacol Ther; 2008 Feb; 83(2):336-41. PubMed ID: 17653139
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
13. The effect of sildenafil on ocular blood flow.
Harris A; Kagemann L; Ehrlich R; Ehrlich Y; López CR; Purvin VA
Br J Ophthalmol; 2008 Apr; 92(4):469-73. PubMed ID: 18369062
[TBL] [Abstract][Full Text] [Related]
14. Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes.
Aversa A; Vitale C; Volterrani M; Fabbri A; Spera G; Fini M; Rosano GM
Diabet Med; 2008 Jan; 25(1):37-44. PubMed ID: 18199130
[TBL] [Abstract][Full Text] [Related]
15. Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.
Mahmud A; Hennessy M; Feely J
J Hum Hypertens; 2001 Oct; 15(10):707-13. PubMed ID: 11607801
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of sildenafil in hypertensive men with erectile dysfunction and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5).
Salvi F; Sarzani R; Giorgi R; Donatelli G; Pietrucci F; Micheli A; Baldoni M; Minardi D; Dessì-Fulgheri P; Polito M; Muzzonigro G; Rappelli A
Int J Impot Res; 2004 Oct; 16(5):412-7. PubMed ID: 15175637
[TBL] [Abstract][Full Text] [Related]
17. Type 5 phosphodiesterase inhibition by sildenafil abrogates acute smoking-induced endothelial dysfunction.
Vlachopoulos C; Tsekoura D; Alexopoulos N; Panagiotakos D; Aznaouridis K; Stefanadis C
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1040-4. PubMed ID: 15533731
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil for pulmonary hypertension.
Lee AJ; Chiao TB; Tsang MP
Ann Pharmacother; 2005 May; 39(5):869-84. PubMed ID: 15827074
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
